The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting

The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical settingThe Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B₂ assay as an evaluation tool of different aspirin dosing regimens in the clinical setting, Published online: 01 June 2018; doi:10.1038/s41408-018-0078-3The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting

Source: Blood Cancer Journal - June 1, 2018 Category: Hematology Authors: Valerio De Stefano Bianca Rocca Alberto Tosetto Denise Soldati Giovanna Petrucci Eloise Beggiato Irene Bertozzi Silvia Betti Giuseppe Carli Monica Carpenedo Daniele Cattaneo Viviana Cavalca Alfredo Dragani Elena Elli Guido Finazzi Alessandra Iurlo Giusepp Source Type: research